论文部分内容阅读
目的:分析研讨单磷酸阿糖腺苷联合喜炎平治疗小儿病毒性脑炎疾病的临床效果。方法:此研究中所研讨的88例患者均随机从2013年4月至2016年2月期间我院收治的小儿病毒性脑炎疾病患儿中选取而出,88例患儿按随机抽签法分两组研讨,对照组44例,研究组44例,对照组接受单磷酸阿糖腺苷治疗,研究组接受单磷酸阿糖腺苷联合喜炎平治疗,治疗后,对比治疗状况。结果:研究组治疗总疗效90.90%比对照组79.55%明显要高,组间数据有统计学意义(P<0.05)。从两组患儿恢复意识时间、脑膜刺激征消失时间、呕吐消失时间、抽搐消失时间、头痛和发热消失时间上来看,研究组比对照组时间短,组间数据有统计学意义(P<0.05)。结论:临床在治疗小儿病毒性脑炎疾病时可考虑将单磷酸阿糖腺苷和喜炎平药物联合使用,疗效突出,各症状得到快速缓解,推广应用价值较大。
OBJECTIVE: To analyze the clinical effects of monophosphate adenosine monophosphate combined with Xiyanping in treating viral encephalitis in children. Methods: All 88 patients studied in this study were randomly selected from children with viral encephalitis in our hospital from April 2013 to February 2016. 88 children were randomly selected by random sampling Two groups of study, the control group of 44 patients, the study group of 44 patients in the control group received monophosphate monophosphate adenosine monophosphate treatment group, the study group received monophosphate glucorapate combined with xiyanping treatment, after treatment, compared to treatment. Results: The total effective rate of 90.90% in study group was significantly higher than 79.55% in control group (P <0.05). From the recovery time of consciousness, the time of disappearance of meningeal irritation, the disappearance of vomiting, the disappearance of twitch, the headache and the disappearance of fever in study group, the study group was shorter than the control group, with statistical significance between the two groups (P <0.05 ). Conclusion: Clinical treatment of children with viral encephalitis disease may consider the combination of phosphorandonoside monophosphate and Xiyanping drugs, the effect is outstanding, the symptoms are rapidly remitted, the promotion and application of greater value.